换一批
换一批Epidermal growth factor receptor (EGFR) structure-based bioactive pharmacophore models for identifying next-generation inhibitors against clinically relevant EGFR mutations.
第一作者：
Pooja S,Panicker
第一单位：
Centre for Nanosciences and Molecular Medicine, Amrita Institute of Medical Sciences and Research Centre, Amrita University, Kochi, Kerala, India.
作者：
主题词
抗肿瘤药(Antineoplastic Agents);计算机辅助设计(Computer-Aided Design);药物设计(Drug Design);人类(Humans);羟肟酸类(Hydroxamic Acids);突变(Mutation);蛋白激酶抑制剂(Protein Kinase Inhibitors);量化构效关系(Quantitative Structure-Activity Relationship);喹唑啉类(Quinazolines);小分子化合物库(Small Molecule Libraries)
DOI
10.1111/cbdd.12977
PMID
28303669
发布时间
2018-12-02
- 浏览60
Chemical biology & drug design
629-636页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
